Therefore, BDMPs may exert their adverse effects on stroke outcome by promoting inflammatory responses and Lactadherin treatment decreases BDMPs and regulates anti-inflammatory responses to improve stroke outcome in mice. The gene discussed is MFGE8; the disease is stroke disorder.